Tempus AI (NASDAQ:TEM) EVP Andrew Polovin Sells 5,398 Shares

Key Points

• Andrew Polovin, EVP of Tempus AI, sold 5,398 shares at an average price of $74.65, totaling approximately $402,960.70, reducing his ownership by 3.93%.
• Tempus AI reported strong quarterly earnings with a revenue increase of 89.5% year-over-year, and EPS of ($0.22), beating analysts' expectations.
• Several analysts have recently adjusted their price targets for Tempus AI, with Guggenheim raising its target from $65.00 to $75.00 and BTIG raising it to $85.00, maintaining a "buy" rating.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) EVP Andrew Polovin sold 5,398 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $402,960.70. Following the sale, the executive vice president directly owned 132,056 shares of the company's stock, valued at $9,857,980.40. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Tempus AI Stock Performance

Shares of TEM traded up $3.43 on Thursday, reaching $76.71. 15,579,085 shares of the company's stock traded hands, compared to its average volume of 12,600,730. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The stock has a market cap of $13.33 billion, a PE ratio of -64.46 and a beta of 4.98. The stock's 50 day simple moving average is $63.48 and its two-hundred day simple moving average is $58.98. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI's revenue was up 89.5% on a year-over-year basis. During the same period last year, the business posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. On average, analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

TEM has been the subject of a number of recent research reports. Needham & Company LLC reissued a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. Guggenheim raised their target price on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. BTIG Research raised their target price on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a research report on Wednesday. Bank of America raised their target price on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Finally, Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Tempus AI has an average rating of "Moderate Buy" and a consensus price target of $67.64.

Hedge Funds Weigh In On Tempus AI

Large investors have recently made changes to their positions in the stock. Concord Wealth Partners boosted its holdings in shares of Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company's stock worth $26,000 after acquiring an additional 308 shares during the period. Allworth Financial LP boosted its holdings in shares of Tempus AI by 5,000.0% in the second quarter. Allworth Financial LP now owns 459 shares of the company's stock worth $29,000 after acquiring an additional 450 shares during the period. Cherry Tree Wealth Management LLC bought a new position in shares of Tempus AI in the first quarter worth $31,000. SouthState Corp boosted its holdings in shares of Tempus AI by 3,761.5% in the second quarter. SouthState Corp now owns 502 shares of the company's stock worth $32,000 after acquiring an additional 489 shares during the period. Finally, University of Texas Texas AM Investment Management Co. bought a new stake in Tempus AI during the first quarter valued at $33,000. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.